XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract]    
Net revenues $ 3,470,544 $ 1,830,633
Cost of goods sold (3,275,800) (1,467,603)
Gross profit 194,744 363,030
OPERATING EXPENSES:    
Selling and marketing expenses (1,868,985) (1,095,108)
General and administrative expenses (7,358,264) (8,211,831)
Research and development expenses (1,569,919) (425,359)
Total operating expenses (10,797,168) (9,732,298)
Loss from operations (10,602,424) (9,369,268)
OTHER EXPENSE:    
Interest (expense) income, net (54,415) 64,201
Income from long-term investment 19,042 5,937
Impairment of long-term investment (1,146,128) 0
Loss on redemption of convertible promissory notes (2,001) 0
Loss on exercise of warrants (212,870) 0
Change in fair value of convertible promissory notes and derivative liability (126,273) 0
Change in fair value of equity securities 653,016 0
Other income (expense), net 358,076 (49,239)
Loss before income taxes (11,113,977) (9,348,369)
Income tax expense 0 0
Net loss (11,113,977) (9,348,369)
Less: net loss attributable to non-controlling interests (156,028) (36,719)
Net loss attributable to the Company's shareholders (10,957,949) (9,311,650)
OTHER COMPREHENSIVE LOSS    
Foreign currency translation adjustment 337,278 253,156
Total comprehensive loss (10,776,699) (9,095,213)
Less: total comprehensive loss attributable to non-controlling interests (180,595) (57,588)
Total comprehensive loss to the Company's shareholders $ (10,596,104) $ (9,037,625)